$8.59
-0.84-8.91%
Last update: Oct 22, 4:05 PM
Atara Biotherapeutics Inc (ATRA) Stock Price, Quote, News & History
ATRANASDAQ
Atara Biotherapeutics stock drops on FDA rejection of EBVALLO BLA for serious post-transplant complication. FDA raises new concerns.
You can purchase shares of Atara Biotherapeutics (NASDAQ:ATRA) through any online brokerage.
Other companies in Atara Biotherapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Atara Biotherapeutics has a consensus price target of $22.42.
The stock price for Atara Biotherapeutics (NASDAQ: ATRA) is $9.43 last updated October 22, 2026 at 4:05 PM EDT.
There are no upcoming dividends for Atara Biotherapeutics.
Atara Biotherapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Atara Biotherapeutics.
Atara Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and...
